Sudarshan Pharma Industries Ltd. - Research Center

---

Results

• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

24.07

9.75

9.55

9.55

9.55

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

76.92

20.03

12.96

10.29

9.20

Loan funds

Secured loans

21.31

25.64

21.36

13.80

10.02

Unsecured loans

12.79

4.94

8.41

7.01

4.46

Total

135.08

60.36

52.28

40.64

33.22

Uses of funds

Fixed assets

Gross block

22.06

8.21

7.46

6.26

3.57

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

2.17

1.74

1.25

0.63

-

Net block

19.89

6.47

6.21

5.64

3.57

Capital work-in-progress

0.01

0.54

-

-

-

Investments

12.44

0.10

0.09

0.04

0.05

Net current assets

Current assets, loans & advances

200.13

130.41

92.77

52.47

46.51

Less : current liabilities & provisions

97.39

77.15

46.80

17.50

16.92

Total net current assets

102.73

53.26

45.98

34.97

29.59

Miscellaneous expenses not written

-

-

-

-

-

Total

135.08

60.36

52.28

40.64

33.22

Notes:

Book value of unquoted investments

12.44

0.10

0.09

0.04

0.05

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

0.20

0.19

0.02

0.03

0.03

Number of equity sharesoutstanding (Lacs)

240.66

97.49

95.47

95.47

95.47